stockrowWaystar Holding Corp.
WAY Healthcare Health Information Services
Waystar Holding Corp.’s revenue for fiscal 2025 (year ended December 2025) was $1.1 billion, up 16.5% from fiscal 2024.
- Revenue
- +21.2%
- EPS
- −10.2%
- Free cash flow
- +23.4%
- Total debt
- +18.4%
Quarter to September 2026, against a year earlier
Follow WAY
Alert me
Waystar Holding Corp. (WAY) Free cash flow
Waystar Holding Corp.'s free cash flow for fiscal 2025 was $283.2M, up 98.7% from $142.5M in fiscal 2024. Over the twelve months to 30 September 2026 it was $264.1M. Waystar Holding Corp. ranks 6th of 44 Health Information Services companies by free cash flow.
Free cash flow, annual
Embed this chart
Annual newest first
| Period | Free cash flow | Change |
|---|---|---|
| FY2025 | $283.2M | 98.73% |
| FY2024 | $142.5M | 375.90% |
| FY2023 | $29.9M | (64.86%) |
| FY2022 | $85.2M | — |
Quarterly newest first
| Period | Free cash flow | Change |
|---|---|---|
| Sep 2026 | $93.9M | 116.97% |
| Jun 2026 | $43.3M | (37.78%) |
| Mar 2026 | $69.6M | 21.61% |
| Dec 2025 | $57.2M | (24.86%) |
| 11 more quarters | Free account |
Free cash flow against peers
| Company | Free cash flow |
|---|---|
| BTSG BrightSpring Health Services, Inc. compare | $492.4M |
| HQY HealthEquity, Inc. compare | $437.0M |
| DOCS Doximity, Inc. compare | $305.7M |
| HNGE Hinge Health Inc. compare | $283.9M |
| WAY Waystar Holding Corp. | $264.1M |
| PRVA Privia Health Group, Inc. compare | $108.1M |
| HTFL Heartflow, Inc. compare | −$59.2M |
| SDGR Schrodinger, Inc. compare | −$116.8M |
| TEM Tempus AI, Inc. compare | −$150.6M |
What Free cash flow is
Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.
Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)
More on WAY
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Beneish M-score
- The full statement